[Highlights in hepatology].
This review highlights recent advances in hepatology, including new insights into the clinical penetrance of hereditary hemochromatosis, the development of non-immunosuppressive cyclosporin A analogs for the treatment of chronic hepatitis C, thrombopoietin receptor agonists for thrombocytopenia in cirrhosis, the development of vasopressin V2 receptor antagonists (vaptans) for the management of ascites and hyponatremia in portal hypertension, the description of chronic hepatitis E in immunosuppressed patients, and the development of sorafenib as the first molecularly targeted therapy with a demonstrated benefit in the treatment of advanced hepatocellular carcinoma. These new developments will be summarized and discussed critically, with a particular emphasis on their potential implications for current and future clinical practice.
Pache
I
I
Service de gastroentérologie et d'hépatologie, CHUV, 1011 Lausanne. Isabelle.Pache@chuv.ch
Leung Ki
E-L
EL
Antonino
A
A
Moradpour
D
D
D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy* / Q000209:etiology